Zesiewicz T - Search Results

1

Quantitative analysis of tremors in welders.

Sanchez-Ramos J, Reimer D, Zesiewicz T, Sullivan K, Nausieda PA. Sanchez-Ramos J, et al. Among authors: zesiewicz t. Int J Environ Res Public Health. 2011 May;8(5):1478-90. doi: 10.3390/ijerph8051478. Epub 2011 May 10. Int J Environ Res Public Health. 2011. PMID: 21655131 Free PMC article.

2

Botulinum toxin A for the treatment of cervical dystonia.

Zesiewicz TA, Stamey W, Sullivan KL, Hauser RA. Zesiewicz TA, et al. Expert Opin Pharmacother. 2004 Sep;5(9):2017-24. doi: 10.1517/14656566.5.9.2017. Expert Opin Pharmacother. 2004. PMID: 15330738 Review.

3

Essential tremor. Epidemiology, diagnosis, and treatment.

Sullivan KL, Hauser RA, Zesiewicz TA. Sullivan KL, et al. Neurologist. 2004 Sep;10(5):250-8. doi: 10.1097/01.nrl.0000138736.07840.b2. Neurologist. 2004. PMID: 15335442 Review.

4

Substantial improvement in a Meige's syndrome patient with levetiracetam treatment.

Zesiewicz TA, Louis ED, Sullivan KL, Menkin M, Dunne PB, Hauser RA. Zesiewicz TA, et al. Mov Disord. 2004 Dec;19(12):1518-21. doi: 10.1002/mds.20233. Mov Disord. 2004. PMID: 15390069

5

Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey.

Zesiewicz TA, Strom JA, Borenstein AR, Hauser RA, Cimino CR, Fontanet HL, Cintron GB, Staffetti JF, Dunne PB, Sullivan KL. Zesiewicz TA, et al. Parkinsonism Relat Disord. 2004 Oct;10(7):417-20. doi: 10.1016/j.parkreldis.2004.04.001. Parkinsonism Relat Disord. 2004. PMID: 15465398

6

Chorea in a patient with cerebral palsy: treatment with levetiracetam.

Recio MV, Hauser RA, Louis ED, Radhashakar H, Sullivan KL, Zesiewicz TA. Recio MV, et al. Mov Disord. 2005 Jun;20(6):762-4. doi: 10.1002/mds.20414. Mov Disord. 2005. PMID: 15747368

7

Levetiracetam for the treatment of essential tremor.

Sullivan KL, Hauser RA, Zesiewicz TA. Sullivan KL, et al. Mov Disord. 2005 May;20(5):640. doi: 10.1002/mds.20437. Mov Disord. 2005. PMID: 15756652 No abstract available.

8

Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.

Zesiewicz TA, Sullivan KL, Maldonado JL, Tatum WO, Hauser RA. Zesiewicz TA, et al. Mov Disord. 2005 Sep;20(9):1205-9. doi: 10.1002/mds.20563. Mov Disord. 2005. PMID: 15954135

9

Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Zesiewicz TA, Elble R, Louis ED, Hauser RA, Sullivan KL, Dewey RB Jr, Ondo WG, Gronseth GS, Weiner WJ; Quality Standards Subcommittee of the American Academy of Neurology. Zesiewicz TA, et al. Neurology. 2005 Jun 28;64(12):2008-20. doi: 10.1212/01.WNL.0000163769.28552.CD. Epub 2005 Jun 22. Neurology. 2005. PMID: 15972843

10

Levetiracetam for the treatment of generalized dystonia.

Sullivan KL, Hauser RA, Louis ED, Chari G, Zesiewicz TA. Sullivan KL, et al. Parkinsonism Relat Disord. 2005 Nov;11(7):469-71. doi: 10.1016/j.parkreldis.2005.05.001. Epub 2005 Jul 12. Parkinsonism Relat Disord. 2005. PMID: 16014339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page